Shanghai Kehua Bio-Engineering Co.,Ltd (SHE:002022)
China
· Delayed Price · Currency is CNY 5.98
+0.03 (0.50%)
May 30, 2025, 3:04 PM CST
SHE:002022 Revenue
Shanghai Kehua Bio-Engineering Co.,Ltd had revenue of 387.88M CNY in the quarter ending March 31, 2025, a decrease of -12.50%. This brings the company's revenue in the last twelve months to 1.70B, down -16.41% year-over-year. In the year 2024, Shanghai Kehua Bio-Engineering Co.,Ltd had annual revenue of 1.76B, down -27.55%.
Revenue (ttm)
1.70B
Revenue Growth
-16.41%
P/S Ratio
1.76
Revenue / Employee
838.06K
Employees
2,033
Market Cap
2.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.76B | -668.88M | -27.55% |
| Dec 31, 2023 | 2.43B | -4.54B | -65.16% |
| Dec 31, 2022 | 6.97B | 2.12B | 43.58% |
| Jan 1, 2022 | 4.85B | 698.88M | 16.82% |
| Dec 31, 2020 | 4.16B | 1.74B | 72.11% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |